Sign Up to like & get
recommendations!
0
Published in 2019 at "Ophthalmology and Therapy"
DOI: 10.1007/s40123-019-0197-3
Abstract: IntroductionDiabetic macular oedema (DMO) remains a significant cause of sight loss in the UK. Despite macular laser and anti-VEGF agents, a large proportion of patients remain with persistent DMO. We present our results of using…
read more here.
Keywords:
acetonide fac;
year;
fluocinolone acetonide;
macular oedema ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Drugs"
DOI: 10.1007/s40265-017-0704-6
Abstract: Diabetic macular oedema (DMO) results from alterations of several biochemical pathways in diabetic eyes. Centre-involving DMO is an important cause of visual loss in diabetes. Anti-vascular endothelial growth factor agents are now the mainstay of…
read more here.
Keywords:
therapeutic options;
macular oedema;
diabetic macular;
options refractory ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Destination Marketing and Management"
DOI: 10.1016/j.jdmm.2018.02.003
Abstract: Abstract Travel-related risk perceptions have become more widespread in recent years due to the increased frequency and intensity of incidents, as well as heightened awareness of risk due to the 24‐hour news cycle and constant…
read more here.
Keywords:
crisis;
role;
visitor;
crisis concierge ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Microvascular research"
DOI: 10.1016/j.mvr.2020.104076
Abstract: The adverse environment in early life can modulate adult phenotype, including blood pressure. Our previous study shows, in a rat streptozotocin (STZ)-induced maternal diabetes model, fetal exposure to maternal diabetes is characterized by established hypertension…
read more here.
Keywords:
dysfunction;
blood pressure;
maternal diabetes;
hypertension ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Psychoneuroendocrinology"
DOI: 10.1016/j.psyneuen.2019.06.017
Abstract: Clinical use of the antipsychotic drug olanzapine (OLA) is associated with metabolic side effects to variable degrees. N-desmethyl-olanzapine (DMO) is one major metabolite of OLA, but its potential involvement in the metabolic responses remains unclear.…
read more here.
Keywords:
metabolic endocrinal;
associated metabolic;
mice;
desmethyl olanzapine ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-73571-6
Abstract: New clinical trials for diabetic macular oedema (DMO) are being designed to prove superiority over aflibercept when this agent is already very effective in improving visual acuity (VA) and DMO. The aim of this study…
read more here.
Keywords:
real world;
inclusion;
early response;
dmo ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Nutricion Hospitalaria"
DOI: 10.20960/nh.1510
Abstract: Introduccion: una de las principales manifestaciones extradigestivas de la enfermedad celiaca es la disminucion de la densidad mineral osea (DMO). La densitometria osea realizada con DXA es el metodo de eleccion para la valoracion de…
read more here.
Keywords:
del;
densidad mineral;
ninos celiacos;
dieta ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Psychiatry"
DOI: 10.3389/fpsyt.2022.930457
Abstract: Objectives The aim of the present study was to investigate a potential relationship between metabolic parameters and steady-state plasma concentrations of olanzapine (OLA) and its metabolite, 4-N'-desmethyl-olanzapine (DMO) in patients with schizophrenia taking therapeutic doses.…
read more here.
Keywords:
relationship;
patients schizophrenia;
dmo;
plasma ... See more keywords